AUTOLOGOUS STEM CELL TRANSPLANTATION AS PART OF FIRST‐LINE THERAPY IN PATIENTS WITH PERIPHERAL T‐CELL LYMPHOMA: A MULTICENTER GELTAMO/FIL STUDY. (12th June 2019)